AgeX Therapeutics Probability of Future Stock Price Finishing Over 0.81
| AGEDelisted Stock | USD 0.74 0.01 1.37% |
AgeX |
AgeX Therapeutics Target Price Odds to finish over 0.81
The tendency of AgeX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.81 or more in 90 days |
| 0.74 | 90 days | 0.81 | nearly 4.46 |
Based on a normal probability distribution, the odds of AgeX Therapeutics to move over $ 0.81 or more in 90 days from now is nearly 4.46 (This AgeX Therapeutics probability density function shows the probability of AgeX Stock to fall within a particular range of prices over 90 days) . Probability of AgeX Therapeutics price to stay between its current price of $ 0.74 and $ 0.81 at the end of the 90-day period is about 11.41 .
Considering the 90-day investment horizon AgeX Therapeutics has a beta of 0.71. This suggests as returns on the market go up, AgeX Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AgeX Therapeutics will be expected to be much smaller as well. Additionally AgeX Therapeutics has an alpha of 0.451, implying that it can generate a 0.45 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). AgeX Therapeutics Price Density |
| Price |
Predictive Modules for AgeX Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AgeX Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.AgeX Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. AgeX Therapeutics is not an exception. The market had few large corrections towards the AgeX Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AgeX Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AgeX Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.45 | |
β | Beta against Dow Jones | 0.71 | |
σ | Overall volatility | 0.10 | |
Ir | Information ratio | 0.06 |
AgeX Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AgeX Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AgeX Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AgeX Therapeutics is now traded under the symbol SER. Please update your portfolios or report it if you believe this is an error. Report It! | |
| AgeX Therapeutics is not yet fully synchronised with the market data | |
| AgeX Therapeutics has some characteristics of a very speculative penny stock | |
| AgeX Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| AgeX Therapeutics has 4.37 M in debt with debt to equity (D/E) ratio of 0.75, which is OK given its current industry classification. AgeX Therapeutics has a current ratio of 0.19, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AgeX to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 142 K. Reported Net Loss for the year was (14.8 M) with profit before taxes, overhead, and interest of 125 K. | |
| AgeX Therapeutics has about 645 K in cash with (7.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 76.0% of AgeX Therapeutics shares are held by company insiders |
AgeX Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AgeX Stock often depends not only on the future outlook of the current and potential AgeX Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AgeX Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 345 K |
AgeX Therapeutics Technical Analysis
AgeX Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. AgeX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AgeX Therapeutics. In general, you should focus on analyzing AgeX Stock price patterns and their correlations with different microeconomic environments and drivers.
AgeX Therapeutics Predictive Forecast Models
AgeX Therapeutics' time-series forecasting models is one of many AgeX Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AgeX Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about AgeX Therapeutics
Checking the ongoing alerts about AgeX Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AgeX Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| AgeX Therapeutics is now traded under the symbol SER. Please update your portfolios or report it if you believe this is an error. Report It! | |
| AgeX Therapeutics is not yet fully synchronised with the market data | |
| AgeX Therapeutics has some characteristics of a very speculative penny stock | |
| AgeX Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| AgeX Therapeutics has 4.37 M in debt with debt to equity (D/E) ratio of 0.75, which is OK given its current industry classification. AgeX Therapeutics has a current ratio of 0.19, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AgeX to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 142 K. Reported Net Loss for the year was (14.8 M) with profit before taxes, overhead, and interest of 125 K. | |
| AgeX Therapeutics has about 645 K in cash with (7.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 76.0% of AgeX Therapeutics shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in AgeX Stock
If you are still planning to invest in AgeX Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AgeX Therapeutics' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |